Mucosal tolerance: A two-edged sword to prevent and treat autoimmune diseases

Clinical Immunology and Immunopathology

Volumn 85, Issue 2, 1997, Pages 119-128

  Xiao, Bao Guo ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CHOLINERGIC RECEPTOR; COLLAGEN; CYTOKINE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; MYELIN BASIC PROTEIN; PURINE P2 RECEPTOR; RETINA S ANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC NEUROPATHY; AUTOIMMUNITY; CLONAL ANERGY; HELPER CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NOSE MUCOSA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UVEITIS;

EID: 0030810311     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4432     Document Type: Review

References (59)

1. Kagnoff, M. F., Mucosal immunology: New frontiers. Immunol. Today 17, 57-60, 1996.
2. Hirabayashi, Y., Kurata, H., Funato, H., Nagamine, T., Aizawa, C., Tamura, S., Shimada, K., and Kurata, T., Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination. Vaccine 8, 243-248, 1990.
3. Ma, C. G., Zhang, G. X., Xiao, B. G., Wang, Z. Y., Link, J., Olsson, T., and Link, H., Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-γ-expressing Th1-like cells and up-regulation of TGF-β mRNA in mononuclear cells. Ann. N.Y. Acad. Sei. 778, 273-287, 1996.
4. Javed, N. H., Gienapp, I. E., Cox, K L., and Whitacre, C. C., Exquisite peptide specificity of oral tolerance in experimental auroimmune encephalomyelitis. J. Immunol. 155,1599-1605, 1995.
5. Miller, A., Lider, O., Al-Sabbagh, A., and Weiner, H. L., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. V. Hierarchy of suppression by myelin basic protein from different species. J. Neuroimmunol. 39, 243-250, 1992.
6. Miller, A., Al-Sabbagh, A., Santos, L.M.B., Das, M.P., and Weiner, H. L., Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J. Immunol. 151, 7307-7315, 1993.
7. Higgins, P. J., and Weiner, H. L., Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol. 140, 440-445, 1988.
8. Bitar, D. M., and Whitacre, C. C., Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell. Immunol. 112, 364-370, 1988.
9. Liu, G. Y., and Wraith, D. C., Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice-Implications for autoimmunity. Int. Immunol. 7, 1255-1263, 1995.
10. Joosten, I., Wauben, M. H. M., Holewijn, M. C., Reske, K, Pedersen, F. L., Roosenboommn, C. F. P., Hensen, E. I., van Eden, W., and Buus, S., Direct binding of autoimmune disease related T cell epitopes to purified Lewis rat MHC class II molecules. Int. Immunol. 6, 751-759, 1994.
11. Metzler, B., and Wraith, D. C., Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5, 1159-1165, 1992.
12. Evavold, B. D., Sloan, L. I., and Alien, P. M., Tickling the TCR: Selective T-cell functions stimulated by altered peptide ligands. Immunol. Today 14, 602-609, 1993.
13. Karin, N., Mitchell, D. J., Brocke, S., Ling, N., and Steinman, L., Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of Interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 180, 2227-2237, 1994.
14. Adorini, L., and Nagy, Z. A., Peptide competition for antigen presentation. Immunol. Today 11, 21-24, 1990.
15. Guery, J. C., Sette, A., Leighton, J., Dragomir, A., and Adorini, L., Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J. Exp. Med. 175, 1345-1352, 1992.
16. Alexander, J., Ruppert, J., Snoke, K., and Sette, A., TCR antagonism and T cell tolerance can be independently induced in a DR-restricted, hemagglutinin-specific T cell clone. Int. Immunol. 6, 363-367, 1994.
17. Franco, A., Southwood, S., Arrhenius, T., Kuchroo, V. K., Grey, H. M., Sette, A., and Ishioka, G. Y., T-cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis. Eur. J. Immunol. 24, 940-946, 1994.
18. Sakaguchi, S., Toda, M., Asano, M., Itoh, M., Moores, S. S., and Sakaguchi, N., T cell-mediated maintenance of nature self-tolerance: Its breakdown as a possible cause of various autoimmune diseases. J. Autoimmun. 9, 211-220, 1996.
19. Wang, Z. Y., He, B., Qiao, J., and Link, H., Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine re ceptor and myelin basic protein: double tolerance. J. Neuroimmunol. 63, 79-86, 1995.
20. Holt, P. G., Immunoprophylaxis of atopy: Light at the end of the tunnel? Immunol. Today 15, 484-489, 1994.
21. Miller, A., Lider, O., and Weiner, H. L., Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174, 791-798, 1991.
22. Lehmann, P., Forsthuber, T., Miller, A., and Sercarz, E. E., Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358, 155-157, 1992.
23. Tisch, R., Yang, X. D., Singer, S. M., Liblau, R. S., Fugger, L., and McDevitt, H. O., Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366, 72-75, 1993.
24. Lu, C. Z., Fredrikson, S., Xiao, B. G., and Link, H., Interleukin-2 secreting cells in multiple sclerosis and controls. J. Neural. Sei. 120, 99-106, 1993.
25. Schluesener, H. J., and Wekerle, H., Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations. J. Immunol. 135, 3128-3133, 1985.
26. Weiner, H. L., Friedman, A., Miller, A., Khoury, S. J., Al-Sabbagh, A., Santos, L. M. B., Sayegh, M., Nussenblatt, R. B., Trentham, D. E., and Hafler, D. A., Oral tolerance: Immunologie mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12, 809-837, 1994.
27. Al-Sabbagh, A., Miller, A., Santos, L. M. B., and Weiner, H. L., Antigen-deriven tissue-specific suppression following oral tolerance: Orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse. Eur. J. Immunol. 24, 2104-2109, 1994.
28. Garside, P., Steel, M., Worthey, E. A., Satoskar, A., Alexander, J., Bluethmann, H., Liew, F. Y., and Mowat, A. M., T helper 2 cells are subject to high dose oral tolerance and are not essential for its induction. J. Immunol. 154, 5649-5655, 1995.
29. Tian, J., Atkinson, M.A., Clare-Salzer, M., Hershenfeld, A., Forsthuber, T., Lehmann, P. V., and Kaufman, D. L., Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183, 1561-1567, 1996.
30. Melamed, D., Fishman-Lovell, J., Uni, Z., Weiner, H. L., and Friedman, A., Peripheral tolerance of Th2 lymphocytes induced by continuous feeding of ovalbumin. Int. Immunol. 8, 717-724, 1996.
31. Meyer, A. L., Benson, J. M., Gienapp, L E., Cox, K L., and Whitacre, C. C., Suppression of murine chronic relapsing experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. J. Immunol. 157, 4230-4238, 1996.
32. Wang, Z. Y., Qiao, J., and Link, H., Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor. J. Neuroimmunol. 44, 209-214, 1993.
33. Wang, Z. Y., Huang, J., Olsson, T., He, B., and Link, H., B cell responses to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis. J. Neural. Sei. 128, 167-174, 1995.
34. Okumura, S., Mclntosh, K, and Drachman, D. B., Oral administration of acetylcholine receptor: Effects on experimental myasthenia gravis. Ann. Neural. 36, 704-713, 1994.
35. Ma, C. G., Zhang, G. X., Xiao, B. G., Link, J., Olsson, T., and Link, H., Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J. Neuroimmunol. 58, 51-60, 1995.
36. Wang, Z. Y., Link, H., Ljungdahl, Å., Höjeberg, B., Link, J., He, B., Qiao, J., Melms, A., and Olsson, T., Induction of interferon-γ, interleukin-4 and transforming growth factor-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell. Immunol. 157, 353-368, 1994.
37. Nussenblatt, R. B., Caspi, R. R., Mahdi, R., Chan, C. C., Roberge, F., Lider, O., and Weiner, H. L., Inhibition of S-Ag induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-Ag. J. Immunol. 144, 1689-1695, 1990.
38. Gregerson, D. S., Obritsch, W. F., and Donoso, L. A., Oral tolerance in experimental autoimmune uveoretinitis: Distinct mechanisms of resistance are induced by low versus high-dose feeding protocols. J. Immunol. 151, 5751-5761, 1993.
39. Caspi, R. R., Stiff, L. R., Morawetz, R., Miller-Rivero, N.E., Chan, C. C., Wiggert, B., Nussenblatt, R. B., Morse, H. C., and Rizzo, L. V., Cytokine-dependent modulation of oral tolerance in a murine model of autoimmune uveitis. Ann. N.Y. Acad. Sei. 778, 315-324, 1996.
40. Dick, A. D., Cheng, Y. F., McKinnon, A., Liversidge, J., and Forrester, J. V., Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. Br. J. Ophthalmol. 77, 171-175, 1993.
41. Dick, A. D., Cheng, Y. F., Liversidge, J., and Forrester, J. V., Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology 82, 625-631, 1994.
42. Liblau, R. S., Singer, S. M., and McDevitt, H. O., Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38, 1995.
43. Maron, R., Blogg, N. S., Polanski, M., Hancock, W., and Weiner, H. L., Oral tolerance to insulin and the insulin B-chain. Ann. N.Y. Acad. Sei. 778, 347-357, 1996.
44. Daniel, D., and Wegmann, D. R., Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administra-tion of insulin peptide B-(9-23). Proc. Natl. Acad. Sei. USA 93, 956-960, 1996.
45. Crisa, L., Mordes, P., and Rossini, A. A., Autoimmune diabetes mellitus in the BB rat. Diabetes Metab. Rev. 8, 4-37, 1992.
46. Mordes, J. P., Schirf, B., Roipko, D., Greiner, D. L., Weiner, H. L., Nelson, P., and Rossini, A. A., Oral insulin does not prevent insulin-dependent diabetes mellitus in BB rats. Ann. N.Y. Acad. Sei. 778, 418-421, 1996.
47. Zhang, Z. J., Lee, C. S. Y., Lider, O., and Weiner, H. L., Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen. J. Immunol. 145, 2489-2493, 1990.
48. Prakken, B. J., van der Zee, R., Anderton, S. M., van Kooten, P., Kuis, W., and van Eden, W., Tolerance to an arthritogenic T-cell epitope of hsp65 and the regulation of experimental arthritis. Ann. N.Y. Acad. Sei. 778, 425-426, 1996.
49. Staines, N. A., Harper, N., Ward, F. J., Thompson, H. S. G., and Bansal, S., Arthritis: Animal models of oral tolerance. Ann. N.Y. Acad. Sei. 778, 297-305, 1996.
50. Staines, N. A., Narper, N., Ward, F. J., Malmstrom, V., Holmdahl, R., and Bansal, S., Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103, 368-375, 1996.
51. Weiner, H. L., Oral tolerance. Proc. Natl. Acad. Sei. USA 91, 10762-10765, 1994.
52. Fukaura, H., Kent, S.O., Pietrusewicz, M.J., Khoury, S.J., Weiner, H. L., and Hafler, D. A., Antigen-specific TGF-β1 secretion with bovine myelin oral tolerization in multiple sclerosis. Ann. N.Y. Acad. Sei. 778, 251-257, 1996.
53. McFarland, H. F., Complexities in the treatment of autoimmune disease. Science 274, 2037-2038, 1996.
54. Blanas, E., Carbone, F. R., Allison, J., Miller, J. F. A. P., and Heath, W. R., Induction of autoimmune diabetes by oral administration of autoantigen. Science 274, 1707-1709, 1996.
55. Drachman, D. B., Okumura, S., Adams, R. N., and Mclntosh, K R., Oral tolerance in myasthenia gravis. Ann. N.Y. Acad. Sei. 778, 258-272, 1996.
56. Sun, J. B., Holmgren, C., and Czerkinsky, C., Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sei. USA 91, 10795-10799, 1994.
57. Metzler, B., and Wraith, DC., Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peotride: Influence of MHC binding affinity. Int. Immunol. 5, 1159-1165, 1992.
58. Wildner, G., Hunig, T., and Thurau, S. R., Orally induced, peptide-specific γ/δ TCR+ cell suppress experimental autoimmune uveitis. Eur. J. Immunol. 26, 2140-2148, 1996.
59. Khare, S.D., Krco, C.J., Pawelski, J.R., Griffiths, M. M., Luthra, H. S., and David, C. S., Oral administration of human collagen peptide 250-270 suppresses collagen-induced arthritis in DBA/1 mice by inhibiting a Thl response. Arthritis Rheum. 37(Suppl.), S398, 1994.